跳至主要内容
临床试验/NCT01886365
NCT01886365已完成不适用

Perioperative Glycemic Control With a Computerized Algorithm vs. Conventional Glycemic Control in Cardio-surgical Patients Undergoing Cardiopulmonary Bypass With Blood Cardioplegia

Universitätsklinikum Hamburg-Eppendorf2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
2
主要终点
Time within a blood glucose corridor of 80 - 150 mg/dl

研究概览

简要总结

The debate about tight glycemic control (TGC) in the operating room and on the intensive care unit is ongoing, especially in cardio-surgical patients treated with blood cardioplegia, due to high blood glucose levels during operations and subsequent high rates of sternal wound infections. We showed in a feasibility study that early computer based insulin therapy starting in the operating room is a safe therapy that allows to better warrant normoglycemia in patients undergoing major cardiac surgery with the use of blood cardioplegia.

详细描述

Patients are enrolled and randomized into 3 groups. Start of therapy is determined as the beginning of cardiopulmonary bypass. Group A: Therapy with computer-based algorithm and measurement of blood glucose every 30 min. Group B: Measurement of blood glucose every 15 min using the identical computer-based algorithm. Group C: Conventional therapy using a fixed insulin dosing scheme. End of therapy is defined as discharge from ICU.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients over 18 scheduled for elective cardiac surgery with the use of cardiopulmonary bypass and blood cardioplegia

排除标准

  • under 18 years of age, or if patients had a premedical history of steroid therapy

结局指标

主要结局

Time within a blood glucose corridor of 80 - 150 mg/dl

时间窗: From start of cardiopulmonary bypass during surgery until discharge from ICU, which is approximately after 48 -72 hrs.

The primary endpoint was defined as the time within a given blood glucose corridor from 80 - 150 mg/dl during therapy

次要结局

  • Hypoglycemic events(From beginning of cardiopulmonary bypass during surgery until discharge from the ICU, which is approximately after 48-72 hrs.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. med. Daniel Reuter

Professor of anesthesiology

Universitätsklinikum Hamburg-Eppendorf

研究点 (2)

Loading locations...

相似试验